NORTHBROOK, Ill., April 17, 2012 /PRNewswire/ -- Healthios Capital Markets, LLC. ("Healthios") is pleased to announce that Ellen S. Baron, Ph.D., has joined the firm as a Managing Director. Dr. Baron is a former General Partner at Oxford Bioscience Partners, where she led numerous investments within the $1 billion portfolio of 149 companies. She has over 25 years of operating and investment expertise across the spectrum of the pharmaceutical and biotechnology industries, with particular emphasis in oncology, neurology, and infectious disease. Among her responsibilities at Healthios, Ellen will lead the firm's biopharmaceutical practice and will be based Boston, MA.
Dr. Baron was recruited by Oxford from her role at Senior Vice President of Business Development at Human Genome Sciences, Inc. Prior to Human Genome Sciences Dr. Baron spent 20 years at Schering-Plough Corporation in both Research and Development and Business Development. Dr. Baron received a B.A. from Goucher College, a Ph.D. in Microbiology from Georgetown University School of Medicine, and a post-doctorate at the Public Health Research Institute in New York.
"We are delighted to have Ellen as part of the Healthios team," said David Loucks, Healthios's CEO. "She is a highly accomplished deal maker, and her background in industry, as a top-tier venture capitalist, and as a trusted advocate of portfolio companies is an ideal fit for our platform."
"Healthios has advised several of Oxford's portfolio companies, so I have had first-hand experience with the team and their techniques," commented Dr. Baron. "As the strategic and investment environment in healthcare remains complex, the interests of strategic buyers, institutional investors and their portfolio companies require a special approach. Healthios's focus, research commitment, managing director involvement, and unique application of technology are truly superior. I look forward to working with my industry colleagues – both old and new – and with the many growth companies which are the foundation of our industry."
Healthios is a boutique investment bank focused exclusively on the global healthcare industry. The mission of the Firm is to unify the promise of the global healthcare industry with the fortunes of those who invest in it, by maximizing value, reducing cost and minimizing risk for the most sophisticated investors, the most active buyers, and the most compelling growth companies. To join our portal, please go to www.healthios.com/hx.